NT-proBNP

Project Name: NT-proBNP as a Marker in Atrial Fibrillation

Project Category: data use project

Heads of Project:

• Prof. Dr. med. Markus Löffler (Leipzig University)
• Prof. Dr. André Scherag (for the Jena University Hospital)

Duration and Status: 1.3.2022 – 31.8.2022, data use completed

Data Types Provided: treatment case data, diagnoses, and laboratory observations

Abstract:
It is sometimes difficult and tedious to reliably diagnose atrial fibrillation, a mostly chronic cardiac arrhythmia, in patients. Ususally, a long-term ECG (electrocardiogram), i.e. a measurement of the heart currents, is used for this purpose. In the NT-proBNP project, the aim is to determine whether the measurement of the biomarker NT-proBNP can be used in addition to the ECG as an indication for a reliable diagnosis. (A biomarker is a biological characteristic that can be measured in blood or tissue samples). For this purpose, the correlation between atrial fibrillation and the occurrence of the biomarker NT-proBNP will be analyzed at all participating university hospitals.

Link: project description at the German Portal for Medical Research Data